Physician

Kevin Dale Schlessel, M.D.

According to 2025 Medicare claims, Kevin Schlessel, M.D. (NPI: 1063490845) practices rheumatology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is COLUMBUS ARTHRITIS CENTER, INC. (NPI: 1952433898; TIN: 311425166) and primary practice location at 43215-1077. Schlessel is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Schlessel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 87,170 HCPCS/CPT codes, and received $1,244,275 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,119 prescription claims across 482 beneficiaries totaling $1,291,817 in drug costs, led by Enbrel Sureclick (Etanercept). 2021 DME data shows 11 claims. Open Payments data shows 117 records totaling $3,480. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,677,762 and ending at $1,291,817. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	370	31,483	$807,824
2016	522	50,553	$1,472,896
2017	473	52,987	$1,421,352
2018	560	61,231	$1,860,004
2019	527	76,813	$2,027,286
2020	456	68,487	$1,505,798
2021	438	66,399	$1,513,855
2022	426	83,164	$1,419,112
2023	418	90,928	$1,321,244
2024	424	87,170	$1,244,275

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	418	3,617	$1,677,762
2016	426	3,425	$2,475,976
2017	441	3,412	$1,989,720
2018	463	3,531	$2,476,074
2019	475	3,358	$1,653,390
2020	440	3,333	$2,031,093
2021	458	3,256	$1,914,572
2022	441	3,083	$1,855,808
2023	416	2,943	$1,670,415
2024	482	3,119	$1,291,817

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$106
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	307	604	$84
80053	Blood test, comprehensive group of blood chemicals	231	348	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	268	445	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	226	347	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	226	343	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	36	1,120	$293,891
Humira(Cf) Pen	Adalimumab	24	896	$279,870
Rinvoq	Upadacitinib	25	990	$206,299
Cimzia (2 Pack)	Certolizumab Pegol	12	322	$65,161
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	464	32,851	$17,473

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	117	$3,480	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin Dale Schlessel, M.D.?

Tedicare shows public-source Medicare data for Kevin Dale Schlessel, M.D. (NPI 1063490845), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Dale Schlessel, M.D. have ACO affiliation data?

Kevin Dale Schlessel, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Kevin Dale Schlessel, M.D.?

Kevin Dale Schlessel, M.D. is linked to COLUMBUS ARTHRITIS CENTER, INC. (billing NPI 1952433898) in the available physician profile data.

Does Kevin Dale Schlessel, M.D. have Open Payments data?

Kevin Dale Schlessel, M.D. has 117 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.